March 09, 2024
2 min watch
Save
VIDEO: Delivery options for wet AMD gene therapy under investigation
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Lejla Vajzovic, MD, FASRS, discusses developments in gene therapy for wet age-related macular degeneration.
Vajzovic said several companies have trials underway to evaluate subretinal, intravitreal and suprachoroidal gene therapy delivery options.
“As you can tell, [this is]exciting stuff in gene therapy,” she said. “Hopefully we’ll have a product in the near future for wet AMD.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Vajzovic reports serving as an advisor and conducting clinical trials for Regenxbio.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.